MoneyWorks4Me

Dr. Lal PathLabs submits conference call transcript

25 Nov 2019 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed about submission of Financial Results, Conference Call Transcript of the Company for Q2 & H1 FY20. 

The above information is a part of company’s filings submitted to BSE.

Peers